Bluewillow
1 known investors
BlueWillow Biologics is a clinical-stage biopharmaceutical company developing NanoVax, an intranasal oil-in-water adjuvant (W805EC) and antigen delivery platform for vaccines. The technology targets infectious disease prevention and pandemic preparedness and is compatible with viral, bacterial, and food antigens.
BiotechHealthtech
Investors · 1
Non-dilutive funding · 12 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2022 | $1.7M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2020 | $3M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2020 | $3M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2020 | $299.6K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $299.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $215.5K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2017 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2010 | $297.3K |
| Environmental Protection Agency (EPA) | Phase II | 2005 | $225K |
| Environmental Protection Agency (EPA) | Phase II | 2005 | $224.7K |
| Environmental Protection Agency (EPA) | Phase I | 2004 | $69.9K |
| Environmental Protection Agency (EPA) | Phase I | 2004 | $69.6K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Bluewillow do?
- BlueWillow Biologics is a clinical-stage biopharmaceutical company developing NanoVax, an intranasal oil-in-water adjuvant (W805EC) and antigen delivery platform for vaccines. The technology targets infectious disease prevention and pandemic preparedness and is compatible with viral, bacterial, and food antigens.
- Who are Bluewillow's investors?
- Bluewillow's investors include Michigan Capital Network.